Xu, X., Subbarao, K. & Cox, N. J. Genetic characterization of the pathogenic influenza A/Goose/Guangdong/1/96 (H5N1) virus: similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong. Virology 261, 15–19 (1999).
Cumulative Number of Confirmed Human Cases for Avian Influenza A(H5N1) Reported to WHO, 2003–2025, 25 August 2025 (WHO, 2025); https://www.who.int/publications/m/item/cumulative-number-of-confirmed-human-cases-for-avian-influenza-a(h5n1)-reported-to-who–2003-2025–25-august-2025
Gilbertson, B. & Subbarao, K. Mammalian infections with highly pathogenic avian influenza viruses renew concerns of pandemic potential. J. Exp. Med. 220, e20230447 (2023).
European Food Safety Authority (EFSA) et al. Drivers for a pandemic due to avian influenza and options for One Health mitigation measures. EFSA J. 22, e8735 (2024).
Nunn, A. et al. Avian influenza and use of the H5N1 vaccine to prevent zoonotic infection in Canada. Can. Med. Assoc. J. 197, E599–E600 (2025).
Branswell, H. H5N1 bird flu virus in Canadian teenager displays mutations demonstrating virus’ risk. STAT News https://www.statnews.com/2024/11/18/bird-flu-pandemic-h5n1-virus-mutations-canada-genomic-analysis/ (2024).
Rapid Risk Assessment Update: Avian Influenza A(H5N1) Clade 2.3.4.4b, Public Health Implications for Canada (Public Health Agency of Canada, 2024); https://www.canada.ca/en/public-health/services/emergency-preparedness-response/rapid-risk-assessments-public-health-professionals/avian-influenza-a-h5n1-clade-2-3-4-4b-update.html
Ford, C. T. et al. Large-scale computational modelling of H5 influenza variants against HA1-neutralising antibodies. eBioMedicine 114, 105632 (2025).
Ward, J. et al. Estimates of epidemiological parameters for H5N1 influenza in humans: a rapid review. BMC Infect. Dis. 25, 1755 (2025).
Genetic sequences of highly pathogenic avian influenza A(H5N1) viruses identified in a person in Louisiana. CDC https://www.cdc.gov/bird-flu/spotlights/h5n1-response-12232024.html (2024).
Rapid Response: Preliminary Guidance on Human Vaccination Against Avian Influenza in a Non-Pandemic Context as of December 2024 (Public Health Agency of Canada, 2025); https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/national-advisory-committee-immunization-statement-rapid-response-preliminary-guidance-human-vaccination-avian-influenza-non-pandemic-december-2024.html
Mostafa, A., Nogales, A. & Martinez-Sobrido, L. Highly pathogenic avian influenza H5N1 in the United States: recent incursions and spillover to cattle. NPJ Viruses 3, 54 (2025).
Rawson, T. et al. A mathematical model of H5N1 influenza transmission in US dairy cattle. Nat. Commun. 16, 4308 (2025).
Nguyen, T.-Q. et al. Emergence and interstate spread of highly pathogenic avian influenza A(H5N1) in dairy cattle in the United States. Science 388, eadq0900 (2025).
Dupas, M.-C. et al. Global risk mapping of highly pathogenic avian influenza H5N1 and H5Nx in the light of epidemic episodes occurring from 2020 onwards. eLife 14, RP104748 (2026).
EFSA Panel on Animal Health and Animal Welfare et al. Preparedness, prevention and control related to zoonotic avian influenza. EFSA J. 23, e9191 (2025).
Cherian, P. & Menon, G. I. Modelling a potential zoonotic spillover event of H5N1 influenza. BMC Public Health 25, 3983 (2025).
HPAI confirmed cases in livestock. USDA https://www.aphis.usda.gov/livestock-poultry-disease/avian/avian-influenza/hpai-detections/hpai-confirmed-cases-livestock (2026).
H5 bird flu: current situation. CDC https://www.cdc.gov/bird-flu/situation-summary/index.html (2026).
Avian Influenza A(H5N1): Canada’s Response (Public Health Agency of Canada, 2025); https://www.canada.ca/en/public-health/services/diseases/avian-influenza-h5n1/canada-response.html
Drolet, M. et al. Time trends in social contacts before and during the COVID-19 pandemic: the CONNECT study. BMC Public Health 22, 1032 (2022).
Antia, R., Regoes, R. R., Koella, J. C. & Bergstrom, C. T. The role of evolution in the emergence of infectious diseases. Nature 426, 658–661 (2003).
Alexander, H. K. & Day, T. Risk factors for the evolutionary emergence of pathogens. J. R. Soc. Interface 7, 1455–1474 (2010).
Yang, Y., Halloran, M. E., Sugimoto, J. D. & Longini, I. M. Detecting human-to-human transmission of avian influenza A (H5N1). Emerg. Infect. Dis. 13, 1348–1353 (2007).
Mellis, A. M. Serologic evidence of recent infection with highly pathogenic avian influenza A(H5) virus among dairy workers—Michigan and Colorado, June–August 2024. MMWR Morb. Mortal. Wkly Rep. 73, 1004–1009 (2024).
Technical report: June 2024 highly pathogenic avian influenza A(H5N1) viruses. CDC https://www.cdc.gov/bird-flu/php/technical-report/h5n1-06052024.html (2025).
Restori, K. H. et al. Preexisting immunity to the 2009 pandemic H1N1 virus reduces susceptibility to H5N1 infection and disease in ferrets. Sci. Transl. Med. 17, eadw4856 (2025).
Li, Z.-N. et al. Population immunity to hemagglutinin head, stalk and neuraminidase of highly pathogenic avian influenza 2.3.4.4b A(H5N1) viruses in the United States and the impact of seasonal influenza on A(H5N1) immunity. Preprint at medRxiv https://doi.org/10.1101/2025.03.30.25323419 (2025).
Skowronski, D. M. et al. Neuraminidase imprinting and the age-related risk of zoonotic influenza. Preprint at medRxiv https://doi.org/10.1101/2025.07.03.25330844 (2025).
Hossain, M. A., Monem, M. A. & Rina, A. A. The growing risk of avian influenza (H5N1) in dairy cows: clinical, economic, and public health consequences. New Microbes New Infect. 62, 101531 (2024).
Leonard, J. et al. Notes from the field: seroprevalence of highly pathogenic avian influenza A(H5) virus infections among bovine veterinary practitioners—United States, September 2024. MMWR Morb. Mortal. Wkly Rep. 74, 50–52 (2025).
Census Profile, 2021 Census of Population (Statistics Canada, 2023); https://www12.statcan.gc.ca/census-recensement/2021/dp-pd/prof/index.cfm?Lang=E
Canadian Business Counts, with Employees, Census Metropolitan Areas and Census Subdivisions, December 2023 (Statistics Canada, 2024); https://www150.statcan.gc.ca/t1/tbl1/en/cv.action?pid=3310080801
Cowling, B. J. et al. Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory-confirmed cases. Lancet 382, 129–137 (2013).
Lehtinen, S., Ashcroft, P. & Bonhoeffer, S. On the relationship between serial interval, infectiousness profile and generation time. J. R. Soc. Interface 18, 20200756 (2021).
Ip, D. K. M. et al. Viral shedding and transmission potential of asymptomatic and paucisymptomatic influenza virus infections in the community. Clin. Infect. Dis. 64, 736–742 (2017).
Montgomery, M. P. et al. The role of asymptomatic infections in influenza transmission: what do we really know. Lancet Infect. Dis. 24, e394–e404 (2024).
Lin, T.-H. et al. A single mutation in bovine influenza H5N1 hemagglutinin switches specificity to human receptors. Science 386, 1128–1134 (2024).
Yang, L. et al. Self-isolation among discharged emergency department patients with suspected COVID-19. Can. J. Emerg. Med. 24, 97–98 (2022).
Smith, L. E. et al. Measuring and increasing rates of self-isolation in the context of COVID-19: a systematic review with narrative synthesis. Public Health 234, 224–235 (2024).
Skowronski, D. M. et al. Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case–control evaluation based on sentinel surveillance system in Canada, autumn 2009. Br. Med. J. 342, c7297 (2011).
Van Buynder, P. G. et al. Protective effect of single-dose adjuvanted pandemic influenza vaccine in children. Influenza Other Respir. Viruses 4, 171–178 (2010).
Gilca, R. et al. Effectiveness of pandemic H1N1 vaccine against influenza-related hospitalization in children. Pediatrics 128, e1084–e1091 (2011).
